Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases.

Jesus A Perez,Javier J Lopez, Claudia C Torres Badillo,Jaya Gill,Santosh Kesari, Peter Novak, Max Temnikov,Roman Byshovets, Oleg Bychkov

Cureus（2022）

引用 0|浏览2

暂无评分

摘要

[This corrects the article DOI: 10.7759/cureus.29921.].

查看译文

关键词

neuro-oncology, zinc, glioblastoma, amyotrophic lateral sclerosis, light isotopes, 64zinc aspartate, oncology clinical trials, supportive oncology, neurology and neuro-oncology, zinc aspartate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要